Single Use Bronchoscopes for Interventional Pulmonology
NCT06596655 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-02-13
Summary
The goal of this pilot single-arm crossover trial is to investigate the feasibility and safety of using single-use flexible bronchoscopes (SUFB) for routine diagnostic and therapeutic interventional pulmonary procedures instead of reusable flexible bronchoscopes (RFB). The main questions it aims to answer are:
Was a decision to crossover from SUFB to RFB (at the discretion of the clinical bronchoscopist) made ?
Bronchoscopist's assessment of the SUFB for each procedure (using a Likert scale 0-10) including:
1. Overall assessment
2. Scope quality
3. Scope handling
4. Scope maneuverability
5. Tool compatibility
6. Suction
7. Lavage
8. Safety
9. Image quality
Participants will undergo bronchoscopy with single use bronchoscopes.
Conditions
- Bronchoscopic Interventions
Interventions
- DEVICE
-
Single use bronchoscope
Use of single use bronchoscopes for interventional pulmonology procedures instead of reusable bronchoscopes.
Sponsors & Collaborators
-
Olympus
collaborator INDUSTRY -
Beth Israel Deaconess Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-23
- Primary Completion
- 2026-05-01
- Completion
- 2027-10-01
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
NCT07119229 ·Status: RECRUITING ·Phase: NA
-
Pharmacokinetic Study to Compare Itepekimab Exposure When Administered With an Autoinjector Versus Prefilled Syringe
NCT06114238 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
NCT07053423 ·Status: RECRUITING ·Phase: PHASE4
-
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
NCT05321420 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
NCT03656926 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection
NCT00794586 ·Status: COMPLETED ·Phase: PHASE2
-
Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
NCT03829618 ·Status: TERMINATED ·Phase: PHASE3
-
Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
NCT03903913 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis
NCT04631016 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Between Different Ways for Using Lidocaine During FB
NCT06563050 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis
NCT02657473 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis
NCT02035488 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection
NCT02102152 ·Status: UNKNOWN ·Phase: NA
-
Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)
NCT06760273 ·Status: RECRUITING
-
Switching From Tobramycin Inhalation Treatment to Tobramycin Inhaler Treatment: The Effect on CF Patients' Adherence and Quality of Life
NCT01749644 ·Status: UNKNOWN
-
A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation
NCT04656275 ·Status: TERMINATED ·Phase: PHASE1
-
Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175
NCT05628740 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT07048262 ·Status: RECRUITING ·Phase: PHASE2
-
JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF
NCT03538301 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis
NCT02714283 ·Status: COMPLETED
-
Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)
NCT01769196 ·Status: TERMINATED ·Phase: PHASE2
-
Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients
NCT03795350 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung
NCT02113397 ·Status: TERMINATED
-
Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)
NCT06663176 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa
NCT01315691 ·Status: WITHDRAWN ·Phase: PHASE3